[Metastasizing primary duodenal cancer. Extended remission in a patient following chemotherapy].
Extended, especially metastatic primary duodenal cancer is thought to be of extraordinary bad prognosis, and is hardly to be influenced by chemotherapy. In the meantime we were able to achieve a 20-month lasting remission in a patient with metastatic duodenal cancer treated with the FAM-regime.
D000231:Adenocarcinoma, Papillary / Q000188:drug therapy* / Q000601:surgery; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D004379:Duodenal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D009362:Neoplasm Metastasis
D008937:Mitomycins; D016685:Mitomycin; D004317:Doxorubicin; D005472:Fluorouracil
Metastasierendes primäres Duodenalkarzinom. Anhaltende Remission bei einem Patienten nach Chemotherapie.